It is difficult for busy health care providers to perform routine screening for older women’s posttraumatic stress symptomatology, due, at least partially, to a paucity of instruments specifically tested on such a population. To address this issue, in this preliminarily study we tested an abbreviated screen from the set of 20 items comprising the Distressing Event Questionnaire (DEQ; Kubany, Leisen, Kaplan, & Kelly, 2000) on a convenience sample of 94 ethnically diverse older women (ages 52–105). This new 5-item derivation, named “Brief Posttraumatic Stress Screening Scale (BPSSS)”, assesses posttraumatic stress based on the Diagnostic and Statistical Manual of Mental Disorders - IV (DSM-IV; American Psychiatric Association, 1994). Its conciseness reduces the likelihood that older women would become fatigued during assessment, making it ideal for use in busy health care settings. Because the BPSSS has only five items, a single factor was hypothesized to account for a large proportion of the variance in its items, in view of the hypothesized cohesiveness of the tool’s five items. We also expected that scores on the screen would correlate (to a certain extent) with those on measures of depression and perceived stress of a non-traumatic and non-medical nature. A standardized alpha of .86 demonstrated high internal consistency of the BPSSS and the exploratory factor analysis showed that one factor accounted for 58% of the five items’ variance. Moreover, the correlations of BPSSS scores with scores on non-traumatic stress and depression were moderate yet significant (r = .37, p < .01 and r = .50, p < .01, respectively).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.